Success for GSK’s Zejula in ovarian cancer

15th July 2019 Uncategorised 0

The drug was found to demonstrate significant improvement in progression free survival for women regardless of their biomarker status.

More: Success for GSK’s Zejula in ovarian cancer
Source: News